Catalyst
Slingshot members are tracking this event:
Heron (HRTX) Expects Commercial Launch of Cinvanti in Q1 2018 for Patients with Chemotherapy-Induced Nausea & Vomiting (CINV)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| HRTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 04, 2018
Occurred Source:
https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-highlights-progress-cinv-and-pain-management
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Commercial Launch, Cinvanti, Cinv, Chemotherapy-induced Nausea And Vomiting
